Skip to content
ETopical – Lifestyle
Home
Sample Page
Author:
Celularity Inc.
Celularity Receives Nasdaq Notice Regarding Form 10-Q
May 29, 2026
Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation
May 1, 2026
Celularity Announces Closing of Transaction with NexGel
April 21, 2026
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
April 17, 2026
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities
March 12, 2026
Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy
March 10, 2026